首页> 外国专利> NEW ANTIBIOTIC SF-767-A AND SF-767-L SUBSTANCES, AND PROCESS FOR THE PRODUCTION OF THESES SUBSTANCES

NEW ANTIBIOTIC SF-767-A AND SF-767-L SUBSTANCES, AND PROCESS FOR THE PRODUCTION OF THESES SUBSTANCES

机译:新型抗生素SF-767-A和SF-767-L物质及其生产过程

摘要

1,254,136. Antibiotics SF-767-A and SF-767-L. MEIJI SEIKA KAISHA Ltd. 22 May, 1969 [24 May, 1968; 28 June, 1968], No. 26051/69. Heading C2A. The novel antibiotics SF-767-A and SF- 767-L or their acid addition salts are obtained by aerobically cultivating Streptomyces microsporeus A.T.C.C. 21384, or a strain thereof producing the said substances, in a medium containing assimilable sources of carbon and nitrogen. Each substance inhibits the growth of Gram-negative; Gram-positive and acid-fast bacteria; is soluble in water, slightly soluble in methanol, and nearly insoluble in ethanol, butanol, acetone, ethyl acetate, benzene, ethylether and n-hexane; has no U.V. absorption between 210 and 360 mÁ; is positive to the Molisch, anthrone and ninhydrin tests but negative to the Benedict, Fehling, Sakaguchi, FeCl 3 , Elson-Morgan and maltol tests; gives a weakly alkaline dextro-rotatory solution in water; migrates towards the cathode on electrophoresis at pH 1À8; and is an aminoglycosidic substance containing C, N, O and H, with the amino group present but no acidic groups. SF-767-A is a white amorphous powder decomposing with gas-evolution at about 190‹ C.; having the elementary composition 45À06% C, 7À40% H, 8À90% N, 39À08% O; a molecular weight of 620; empirical formula C 23 H 44 N 4 O 15 ; an optical rotation of [α]D = + 67 degrees in 1% aqueous solution; and an I.R. absorption spectrum as shown in Fig. 2 above with bands at the wave numbers: 3400, 2900, 1595, 1460, 1350, 1130 (shoulder) and 1010 cm.SP-1/SP. SF-767-L is a white amorphous powder decomposing with gas evolution at about 192‹ C.; having the elementary composition 43À58% C., 6À80% H, 8À62% N, 40À75% O; a molecular weight of 682; empirical formula C 23 H 46 N 4 O 16 ; an optical rotation of [α]D = + 69 degrees in 1% aqueous solution; and an I.R. absorption spectrum as shown above in Fig. 5 with bands at the wave numbers: 3420, 2910, 1585, 1480, 1350, 1130 (shoulder) and 1010. SF-767-A is produced throughout the fermentation whereas SF-767-L tends to be formed in the latter stages thereof; also incubation below 30‹ C. favours formation of the first-mentioned substance, and production of the latter substance is encouraged above 30‹ C. The antibiotics may be recovered from the culture medium by absorption on charcoal at alkaline pH followed by elution at acid pH; or by absorption on and elution from ion exchange resin; or by precipitation with a water-miscible organic solvent, if required in the presence of an acid, when the precipitate is the acid-addition salt. They may be purified by ion exchange chromatography, and the solutions concentrated to dryness to give the solid antibiotic. The two antibiotics may be separated by absorption from aqueous solution on to a cationexchange resin column followed by elution with dilute ammonia, when the SF-767-L elutes first. The separate antibiotics are converted to their N-acetylates with acetic anhydride in methanol; also their sulphate addition salts are prepared. Pharmaceutical compositions comprise the antibiotics SF-767-A or SF-767-L or their sulphate salts in aqueous injectable solution.
机译:1,254,136。抗生素SF-767-A和SF-767-L。 MEIJI SEIKA KAISHA Ltd. 1969年5月22日[1968年5月24日; 1968年6月28日],第26051/69号。标题C2A。新型抗生素SF-767-A和SF-767-L或其酸加成盐是通过有氧培养小孢子链霉菌A.T.C.C而获得的。在含有可吸收的碳和氮源的培养基中产生21384或其产生所述物质的菌株。每种物质都会抑制革兰氏阴性菌的生长。革兰氏阳性和耐酸细菌;易溶于水,微溶于甲醇,几乎不溶于乙醇,丁醇,丙酮,乙酸乙酯,苯,乙醚和正己烷;没有U.V.吸收在210至360mÁ之间;对Molisch,蒽酮和茚三酮测试呈阳性,但对Benedict,Fehling,Sakaguchi,FeCl 3,Elson-Morgan和麦芽酚测试呈阴性;在水中产生弱碱性的右旋旋转溶液;在pH 1-8电泳时向阴极迁移;是含有C,N,O和H的氨基糖苷类物质,其中存在氨基,但没有酸性基团。 SF-767-A是一种白色无定形粉末,在约190℃时会发生气体逸散。元素组成为C 45‑06%,H 7‑40%,N 8‑90%,O 39‑08%分子量为620;实验式C 23 H 44 N 4 O 15;在1%的水溶液中,[α] D = + 67度的旋光度;和I.R.吸收光谱如图2所示,其波带分别为:3400、2900、1595、1460、1350、1130(肩)和1010 cm。 -1 。 SF-767-L是一种白色无定形粉末,在约192°C会分解为气体。具有43.58%C.,6-80%H,8-62%N,40-75%O的元素组成;分子量为682;实验公式C 23 H 46 N 4 O 16;在1%的水溶液中,[α] D = + 69度的旋光度;和I.R.吸收光谱如图5所示,其波带分别为:3420、2910、1585、1480、1350、1130(肩)和1010。在整个发酵过程中会产生SF-767-A,而SF-767-L倾向于在其后阶段形成;在30℃以下温育也有利于第一种物质的形成,在30℃以上则鼓励后一种物质的产生。可通过在碱性pH下吸附在木炭上,然后在酸性条件下洗脱,从培养基中回收抗生素。 pH值或被离子交换树脂吸收和洗脱;当沉淀物是酸加成盐时,或者如果需要的话在酸的存在下通过与水混溶的有机溶剂的沉淀来沉淀。它们可以通过离子交换色谱法纯化,并将溶液浓缩至干,得到固体抗生素。 SF-767-L首先洗脱时,可以通过从水溶液吸收到阳离子交换树脂柱上,然后用稀氨水洗脱来分离这两种抗生素。单独的抗生素在甲醇中用乙酸酐转化为N-乙酰化物。还制备了它们的硫酸盐加成盐。药物组合物在注射水溶液中包含抗生素SF-767-A或SF-767-L或其硫酸盐。

著录项

  • 公开/公告号GB1254136A

    专利类型

  • 公开/公告日1971-11-17

    原文格式PDF

  • 申请/专利权人 MEIJI SEIKA KAISHA LTD.;

    申请/专利号GB19690026051

  • 发明设计人

    申请日1969-05-22

  • 分类号C07G11/00;G11B33/02;

  • 国家 GB

  • 入库时间 2022-08-23 08:09:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号